C9370A

EU Classification

Water 7732-18-5 > 70 231-791-2 Aliphatic diol Proprietary < 10 Proprietary space 1-(2-hydroxyethyl)-2-pyrrolidone 3445-11-2 < 10 222-359-4 2-pyrrolidone 616-45-5 < 7.5 210-483-1 R36/38 space Substituted napthalenesulfonate salt #9 Proprietary Proprietary Xi, N; R41, 51/53 Azonaphthalenesulfonate salt #1 Proprietary < 2.5 Proprietary space Composition comments This ink supply contains an aqueous ink formulation. This product was evaluated according to the criteria of the National Occupational Health and Safety Commission (NOHSC) Australia. 3. HAZARDS IDENTIFICATION space Classification This product is not classified according to EU Directive 1999/45/EC. space space Emergency Overview Contact with skin and eyes may result in irritation. Acute health effects Any potential hazards are presumed to be due to exposure to the components. space Skin contact space 1-(2-hydroxyethyl)-2-pyrrolidone Contact with skin may result in irritation. 2-pyrrolidone Contact with skin may result in irritation. Aliphatic diol Contact with skin may result in irritation. space Eye contact space 1-(2-hydroxyethyl)-2-pyrrolidone Contact with eyes may result in irritation. 2-pyrrolidone Contact with eyes may result in irritation. Aliphatic diol Contact with eyes may result in irritation. Azonaphthalenesulfonate salt #1 Contact with eyes may result in irritation. Substituted napthalenesulfonate salt #9 Contact with eyes may result in serious damage and irreversible eye coloration. Risk of serious damage to eyes. space Inhalation space 1-(2-hydroxyethyl)-2-pyrrolidone Inhalation may result in respiratory irritation. 2-pyrrolidone Inhalation may result in respiratory irritation. Aliphatic diol Inhalation may result in respiratory irritation. space Ingestion space 1-(2-hydroxyethyl)-2-pyrrolidone Ingestion may result in nausea, vomiting and diarrhea. 2-pyrrolidone Ingestion may result in nausea, vomiting and diarrhea. space Potential health effects Routes of exposure Potential routes of overexposure to this product are skin and eye contact Inhalation of vapor and ingestion are not expected to be significant routes of exposure for this product under normal use conditions. Complete toxicity data are not available for this specific formulation. space Chronic health effects None known. space Carcinogenicity None of the components present in this formulation at concentrations equal to or greater than 0.1% are listed by EU, MAK, IARC, NTP or OSHA. space Other information Australia: Non-hazardous substance. Non-dangerous goods. . space FIRST AID MEASURES space